Related Experiment Video
Updated: May 18, 2026

08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Mesoporous silica nanoparticles: A multifunctional nano therapeutic system
1Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, USA.
Summary
Mesoporous silica nanoparticles (MSNP) offer advanced drug delivery, targeting diseases like cancer. These nanocarriers provide multifunctional advantages for efficient and safe therapeutic delivery and imaging.
Area of Science:
- Biomedical Engineering
- Materials Science
- Nanotechnology
Background:
- Efficient and safe drug delivery remains a significant challenge in medicine.
- Nanotechnology, particularly nano drug delivery systems (DDS), shows promise for targeted therapy.
- Conventional DDS include lipid and polymer-based nanocarriers.
Purpose of the Study:
- To explore the potential of mesoporous silica nanoparticles (MSNP) as advanced DDS.
- To highlight the unique advantages of MSNP compared to other nanocarriers.
Main Methods:
- Development and characterization of engineered nanomaterials.
- Utilizing MSNP as a platform for delivering therapeutic elements.
- Investigating MSNP capabilities in cellular and in vivo models.
Main Results:
- MSNP function as multifunctional delivery platforms for various therapeutic agents.
- MSNP effectively package both hydrophobic and hydrophilic drug molecules.
- MSNP enable controlled, on-demand drug release and imaging for theranostic applications.
Conclusions:
- MSNP represent a novel class of multifunctional nanocarriers with significant advantages.
- MSNP show great potential for targeted drug delivery, particularly in cancer therapy.
- The unique properties of MSNP position them as superior alternatives to conventional nanocarriers.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

